Healthcare provider profile · identity verified

Manojkumar Chandulal Patel

Internal Medicine · DUBLIN, GA · NPI 1932134830

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	532	138
Amlodipine Besylate	Amlodipine Besylate	499	128
Famotidine	Famotidine	260	59
Levothyroxine Sodium	Levothyroxine Sodium	239	55
Carvedilol	Carvedilol	238	62
Pantoprazole Sodium	Pantoprazole Sodium	217	66
Potassium Chloride	Potassium Chloride	216	56
Simvastatin	Simvastatin	210	53
Albuterol Sulfate Hfa	Albuterol Sulfate	208	57
Lisinopril	Lisinopril	203	53
Metformin Hcl	Metformin Hcl	201	51
Hydralazine Hcl	Hydralazine Hcl	199	61
Eliquis	Apixaban	189	25
Losartan Potassium	Losartan Potassium	184	45
Furosemide	Furosemide	178	63
Hydrochlorothiazide	Hydrochlorothiazide	174	42
Metoprolol Tartrate	Metoprolol Tartrate	129	36
Glimepiride	Glimepiride	106	25
Clopidogrel	Clopidogrel Bisulfate	105	26
Gabapentin	Gabapentin	104	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	94	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	90	29
Omeprazole	Omeprazole	89	20
Tamsulosin Hcl	Tamsulosin Hcl	89	23
Pravastatin Sodium	Pravastatin Sodium	83	19
Nifedipine Er	Nifedipine	76	19
Atenolol	Atenolol	71	22
Trazodone Hcl	Trazodone Hcl	71	14
Diclofenac Sodium	Diclofenac Sodium	70	31
Clonidine Hcl	Clonidine Hcl	68	15
Rosuvastatin Calcium	Rosuvastatin Calcium	68	21
Metoprolol Succinate	Metoprolol Succinate	67	22
Colchicine	Colchicine	57	13
Montelukast Sodium	Montelukast Sodium	57	13
Sertraline Hcl	Sertraline Hcl	56	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	54	37
Humalog	Insulin Lispro	50	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	49	suppressed
Mirtazapine	Mirtazapine	49	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	11
Allopurinol	Allopurinol	45	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	13
Fluticasone Propionate	Fluticasone Propionate	44	20
Meloxicam	Meloxicam	43	22
Prednisone	Prednisone	42	22
Donepezil Hcl	Donepezil Hcl	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	15
Azithromycin	Azithromycin	37	32
Benazepril Hcl	Benazepril Hcl	36	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	36	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Trulicity	Dulaglutide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	11
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	24	suppressed
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Dulera	Mometasone/Formoterol	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Cephalexin	Cephalexin	22	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	20	suppressed
Moxifloxacin	Moxifloxacin Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Amoxicillin	Amoxicillin	19	17
Ezetimibe	Ezetimibe	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Metolazone	Metolazone	19	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Mupirocin	Mupirocin	17	16
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Levemir	Insulin Detemir	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Torsemide	Torsemide	15	suppressed
Valsartan	Valsartan	15	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	12
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Finasteride	Finasteride	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Comfort Ez Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error